N@N

Wright Medical Group, Inc. Reports Inducement Stock Option Grant to Raymond C. Kolls under NASDAQ Marketplace Rule 5635

^{Published on 2010-06-04 18:20:33 - Market Wire}
 

ARLINGTON, Tenn.--([ BUSINESS WIRE ])--Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, announced that on May 31, 2010, the Compensation Committee of its Board of Directors granted an inducement option grant to Mr. Raymond C. Kolls as a part of his employment compensation. This press release is being made pursuant to NASDAQ listing rule 5635(c)(4) related to inducement grants. Wright announced on May 28, 2010 that Mr. Kolls joined the Companya™s executive staff as Sr. Vice President, General Counsel and Secretary. Mr. Kolls brings to Wright over 20 years of experience in corporate governance, commercial transactions and employment law. Most recently, he served as Sr. Vice President, General Counsel and Secretary for Orthofix International NV, a public medical device company that specializes in products for spinal, orthopaedic and sports medicine applications. In his career, Mr. Kolls has completed in excess of $3.5 billion in commercial transactions of all types including mergers and acquisitions, as well as product development and commercialization agreements. Prior to joining Orthofix in 2004, he spent nine years with global transportation leader CSX Corporation in roles of increasing responsibility for the parent organization and several of its subsidiaries, ultimately serving as Associate General Counsel. From 1988 to 1995, Mr. Kolls practiced labor and employment law with the firm Morgan, Lewis, & Bockius where he served such high profile clients as Major League Baseball and American Airlines. Mr. Kolls earned his Bachelora™s degree in Government from Georgetown University in 1985 and his Juris Doctor degree from Georgetown University Law Center in 1988.

"We believe the inducement stock option grant will strengthen Ray's commitment to our welfare and promote an identity of interest between our stockholders and him."

The Compensation Committee of the Board of Directors approved the issuance of an inducement option grant to purchase up to 65,000 shares of Wright's common stock to Mr. Kolls. The exercise price of this option is $16.43, which is the closing price of Wright's common stock on the day prior to grant. The stock options vest and become exercisable in four equal, annual installments beginning on the first anniversary of the grant, conditioned on Mr. Kolls continued employment. The stock options expire ten years after the date of grant. The stock options were granted as an inducement material to Mr. Kolls' employment.

aOn behalf of Wright Medical, I'd like to reiterate that Ray Kolls brings a breadth of experience that is perfectly suited for us,a said Gary D. Henley, Wrighta™s President & CEO. aWe believe the inducement stock option grant will strengthen Ray's commitment to our welfare and promote an identity of interest between our stockholders and him.a

Wright Medical Group, Inc. is a global orthopaedic medical device company and a leading provider of surgical solutions for the foot and ankle market. The Company specializes in the design, manufacture and marketing of devices and biologic products for extremity, hip and knee repair and reconstruction. The Company has been in business for 60 years and markets its products in over 60 countries worldwide. For more information about Wright Medical, visit the Companya™s website at [ www.wmt.com ].